Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer.
about
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumoursPhase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice.Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours.The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancerNucleoside analogs: ready to enter the era of precision medicine?Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor ELPharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous infusion.Influence of infusion method on gemcitabine pharmacokinetics: a controlled randomized multicenter trial.Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.
P2860
Q33364005-138F1747-CB02-43C6-893B-7BF5526D7932Q33404024-3FF5ABD6-E6EF-47F2-9FDC-F18B3D61D1F4Q33813555-081EEF70-8AB6-4453-AF3C-F4F683C8ED1BQ33896659-AAB1AF3B-C9BB-4302-9684-23F48CA89E9BQ34609029-DDB9914E-1EAC-4D42-BF00-6B5551B3B4EAQ35013477-473E97A4-A337-4CA4-B839-9C045E74E863Q36303474-630C8BE6-2652-405C-9559-B3DC0A2DDBBBQ38842938-94054B74-A9FA-4E8A-BF47-EBFB1D330D10Q42759005-A613D775-D52F-4EF0-9B3C-11D15437A968Q46974296-BBCBAD0A-3696-4329-9AAC-B85A22B83DA9Q53178778-004FB2B2-0469-4E48-AD2A-F912EAB6EF31Q55054679-C675D541-3BD2-4955-9289-2F35E675B6CE
P2860
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@ast
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@en
type
label
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@ast
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@en
prefLabel
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@ast
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@en
P2093
P356
P1433
P1476
Drug distribution and pharmaco ...... th non-small-cell lung cancer.
@en
P2093
P304
P356
10.1023/A:1013133415945
P577
2001-11-01T00:00:00Z